Shuqian Xu

538 total citations
20 papers, 381 citations indexed

About

Shuqian Xu is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Shuqian Xu has authored 20 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Shuqian Xu's work include Platelet Disorders and Treatments (7 papers), CRISPR and Genetic Engineering (4 papers) and Acute Myeloid Leukemia Research (2 papers). Shuqian Xu is often cited by papers focused on Platelet Disorders and Treatments (7 papers), CRISPR and Genetic Engineering (4 papers) and Acute Myeloid Leukemia Research (2 papers). Shuqian Xu collaborates with scholars based in China, United States and United Kingdom. Shuqian Xu's co-authors include Ming Hou, Jun Peng, Qiuming Yao, Xinguang Liu, Luca Pinello, Daniel E. Bauer, Daoxin Ma, Hong Li, Qizhao Li and Haiyan Li and has published in prestigious journals such as Nature Genetics, Blood and PLoS ONE.

In The Last Decade

Shuqian Xu

18 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuqian Xu China 10 189 148 102 72 53 20 381
Tadasu Tobita Japan 10 206 1.1× 213 1.4× 66 0.6× 42 0.6× 35 0.7× 12 381
Antonella Russo Rossi Italy 12 151 0.8× 92 0.6× 140 1.4× 129 1.8× 59 1.1× 23 384
Masakazu Sawanobori Japan 9 166 0.9× 97 0.7× 38 0.4× 80 1.1× 44 0.8× 17 357
Frank Richard Germany 9 62 0.3× 116 0.8× 68 0.7× 21 0.3× 42 0.8× 17 372
Yi-Cheng Wang United States 12 288 1.5× 276 1.9× 55 0.5× 50 0.7× 29 0.5× 15 517
Barbora Ravčuková Czechia 12 35 0.2× 82 0.6× 48 0.5× 98 1.4× 43 0.8× 22 299
Muhammed Iraqi Israel 11 86 0.5× 44 0.3× 25 0.2× 61 0.8× 24 0.5× 17 268
Shingo Ishimori Japan 13 67 0.4× 184 1.2× 28 0.3× 24 0.3× 38 0.7× 47 392
Laixi Bi China 12 102 0.5× 199 1.3× 38 0.4× 105 1.5× 24 0.5× 15 385
V. Picard France 9 248 1.3× 107 0.7× 111 1.1× 16 0.2× 6 0.1× 11 420

Countries citing papers authored by Shuqian Xu

Since Specialization
Citations

This map shows the geographic impact of Shuqian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuqian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuqian Xu more than expected).

Fields of papers citing papers by Shuqian Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuqian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuqian Xu. The network helps show where Shuqian Xu may publish in the future.

Co-authorship network of co-authors of Shuqian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuqian Xu. A scholar is included among the top collaborators of Shuqian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuqian Xu. Shuqian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wei, Zhichen, Linlin Shao, Shuqian Xu, et al.. (2024). Case report: Successful therapy with azacitidine for acute myeloid leukemia with NUP98::RARG resembling acute promyelocytic leukemia. Frontiers in Oncology. 14. 1460557–1460557. 1 indexed citations
3.
Li, Qian, Geneviève Marcoux, Johan Rebetz, et al.. (2024). Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP). Autoimmunity Reviews. 23(12). 103677–103677. 9 indexed citations
4.
Yang, Fei, Shuqian Xu, Chao Huang, et al.. (2023). Therapeutic genome editing of an aberrant splice site in β-thalassemia by CRISPR/Cas9 with multiple sgRNAs. Genes & Diseases. 11(1). 15–18. 2 indexed citations
5.
6.
Liu, Lu, Yu Hou, Shuqian Xu, et al.. (2023). The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia. Annals of Hematology. 102(9). 2317–2327. 4 indexed citations
7.
8.
Lai, Yongrong, et al.. (2022). Application of Gene Therapy in Hemophilia. Current Medical Science. 42(5). 925–931. 7 indexed citations
9.
Liu, Nan, Shuqian Xu, Qiuming Yao, et al.. (2021). Transcription factor competition at the γ-globin promoters controls hemoglobin switching. Nature Genetics. 53(4). 511–520. 57 indexed citations
10.
Liu, Nan, Shuqian Xu, Qiuming Yao, et al.. (2021). Author Correction: Transcription factor competition at the γ-globin promoters controls hemoglobin switching. Nature Genetics. 53(4). 586–586. 2 indexed citations
11.
12.
Li, Qizhao, et al.. (2021). Magnitude and Temporal Trend of the Chronic Myeloid Leukemia: On the Basis of the Global Burden of Disease Study 2019. JCO Global Oncology. 7(7). 1429–1441. 26 indexed citations
13.
Wang, Shuwen, Qi Feng, Yanqi Zhang, et al.. (2021). Novel factor VII gene mutations in six families with hereditary coagulation factor VII deficiency. Journal of Clinical Laboratory Analysis. 35(9). e23905–e23905. 5 indexed citations
14.
Zhao, Yajing, Panpan Han, Lei Liu, et al.. (2019). Indirubin modulates CD4+ T‐cell homeostasis via PD1/PTEN/AKT signalling pathway in immune thrombocytopenia. Journal of Cellular and Molecular Medicine. 23(3). 1885–1898. 22 indexed citations
15.
Xu, Shuqian, Kevin Luk, Qiuming Yao, et al.. (2019). Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia. Blood. 133(21). 2255–2262. 59 indexed citations
16.
Xu, Shuqian, et al.. (2016). Comparison of mercury sulfides with mercury chloride and methylmercury on hepatic P450, phase-2 and transporter gene expression in mice. Journal of Trace Elements in Medicine and Biology. 37. 37–43. 17 indexed citations
17.
Zhou, Hai, Yu Hou, Xuena Liu, et al.. (2015). Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia. Thrombosis and Haemostasis. 113(5). 1021–1034. 45 indexed citations
18.
Hu, Yu, Haiyan Li, Lei Zhang, et al.. (2012). Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia. Human Immunology. 73(6). 629–635. 74 indexed citations
19.
Xu, Shuqian, Chunyan Wang, Xiaojuan Zhu, et al.. (2012). Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia. Annals of Hematology. 91(10). 1623–1631. 16 indexed citations
20.
Yang, Qing, Shuqian Xu, Xiaofang Li, et al.. (2011). Pathway of Toll-Like Receptor 7/B Cell Activating Factor/B Cell Activating Factor Receptor Plays a Role in Immune Thrombocytopenia In Vivo. PLoS ONE. 6(7). e22708–e22708. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tadasu Tobita Breakdown of academic impact, for papers by Antonella Russo Rossi Breakdown of academic impact, for papers by Masakazu Sawanobori Breakdown of academic impact, for papers by Frank Richard Breakdown of academic impact, for papers by Yi-Cheng Wang Breakdown of academic impact, for papers by Barbora Ravčuková Breakdown of academic impact, for papers by Muhammed Iraqi Breakdown of academic impact, for papers by Shingo Ishimori Breakdown of academic impact, for papers by Laixi Bi Breakdown of academic impact, for papers by V. Picard
Rankless by CCL
2026